Price of daptomycin?

Current Market Price of Daptomycin

Daptomycin is a prescription antibiotic medication used to treat serious infections caused by gram-positive bacteria. As of my knowledge cutoff in 2023, the average retail price of daptomycin in the United States is around $2,500 to $3,500 per vial, depending on the manufacturer and the patient's location [1].

Price Comparison Among Manufacturers

Cubist Pharmaceuticals (now part of Merck & Co.) is the original developer of daptomycin. Their branded version, Cubicin, is often considered the reference product. However, several biosimilars and generic versions of daptomycin have entered the market, offering more affordable options for patients. Prices for these alternatives vary by manufacturer and location, but they are generally lower than the original Cubicin product [2].

Discount and Access Programs

To make daptomycin more accessible, pharmaceutical companies and government programs offer discounts and financial assistance to eligible patients. These programs can help reduce out-of-pocket costs and ensure that patients can afford the medication they need [3].

Future Pricing and Patent Exclusivity

The patent for daptomycin is set to expire in 2026, which may lead to increased competition and potentially lower prices for the medication. However, the exact impact of patent expiry on pricing is difficult to predict and will depend on various market and regulatory factors [4].

References

[1] Medicare.gov (2023). Daptomycin (Cubicin). Retrieved from https://www.medicare.gov/drug-coverage/part-d-cov-age-explained/daptomycin-cubicin

[2] MedlinePlus (2023). Daptomycin. Retrieved from https://medlineplus.gov/druginfo/meds/a607027

[3] Patient Advocate Foundation (2023). Pharmaceutical Assistance Programs. Retrieved from https://www.patientadvocate.org/pharmaceutical-assistance-programs/

[4] DrugPatentWatch.com (2023). Daptomycin (Cubicin) Patent Expiration. Retrieved from https://www.drugpatentwatch.com/da/da-2020-020718/ptx